NCT07373756 is a Phase 4 clinical trial of Aspirin in Pregnancy Induced Hypertension (PIH), sponsored by Dr. Sunita Pun.

Who is sponsoring NCT07373756?

NCT07373756 is sponsored by Dr. Sunita Pun.

What drugs are being tested in NCT07373756?

Interventions in NCT07373756: Aspirin.

What condition does NCT07373756 study?

NCT07373756 studies Pregnancy Induced Hypertension (PIH).

Is NCT07373756 still recruiting?

NCT07373756 is currently not yet recruiting. Last updated 28 January 2026.

Last reviewed 2026-01-28 · How we verify

NCT07373756

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk Pregnant Women

Not yet recruiting Phase 4 Last updated 28 January 2026

What this trial tests

Phase 4 trial testing Aspirin in Pregnancy Induced Hypertension (PIH) in 86 participants. Not yet recruiting.

Timeline

15 January 2026

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	Dr. Sunita Pun
Phase	Phase 4
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	86
Start date	15 January 2026
Primary completion	31 December 2026
Estimated completion	31 December 2026

Drugs / interventions tested

Aspirin — full drug profile →

Conditions studied

Pregnancy Induced Hypertension (PIH) — all drugs for Pregnancy Induced Hypertension (PIH) →

Sponsor

Dr. Sunita Pun

Who can join

18 and older, female only, with Pregnancy Induced Hypertension (PIH). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Preeclampsia in pregnancy is a dreaded complication which has both fetal and maternal adverse outcomes. Studies and WHO have advocated that this complication can be prevented by Aspirin. However which dose is more effective in preventing preeclampsia, whether 75mg or 150mg, will be known from this study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Aspirin

Trials testing the same drug.

NCT07525635 — Aspirin Dosing in Pregnancy · EARLY_PHASE1 · not yet recruiting
NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting
NCT07180472 — Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol · Phase 4 · not yet recruiting
NCT06638151 — Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime) · Phase 2 · recruiting
NCT07153744 — Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction · Phase 4 · not yet recruiting

Other recruiting trials for Pregnancy Induced Hypertension (PIH)

Currently open trials in the same condition.

NCT07470320 — Placental Biology in Health and Disease · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07373756 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. Sunita Pun
Last refreshed: 28 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07373756.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing